Matrix metalloproteinases and their inhibitors in correlation to proliferative and classical tumour markers during surgical therapy of colorectal liver metastases

Abstract

Abstract:Objectives: Classical and proliferative tumour markers and matrix metalloproteinases and their tissue inhibitors refl ect the features of malignancy and are useful in prediction of prognosis in patients with colorectal liver metastases. There is very limited information about their physiological functions during regeneration and healing of liver parenchyma after any type of liver surgery for malignancy. Methods: The presented study included the patients, who underwent following surgical procedures for CLM, benign liver lesions and inguinal hernias: Group A: 22 patients with inguinal hernias, Group B: 26 patients with benign liver lesions, Group C: 30 patients with colorectal liver metastases (CLM) who were treated by radiofrequency ablation, Group D: 41 patients with CLM who underwent a radical surgical therapy -resection, and Group E: 22 patients with inoperable CLM who underwent an explorative laparotomy without any surgical procedure. Results: The preoperative and postoperative serum levels of CEA, CA 19-9, TK, TPA, TPS, MMP-2, MMP-9, TIMP-1, and TIMP-2 were statistically analyzed and compared within the groups to estimate the infl uence of a surgical procedure type. These results refl ect the infl uence of surgical procedure on the serum levels of studied tumour markers during operation. Conclusions: It was the fi rst description using these types of comparison to all metalloproteinases, their inhibitors, and proliferative and classical tumour markers. It could help us to estimate the critical relations of these tumour markers in prognoses of disease free survival or overall survival in patients after a surgical procedure for CLM (Tab. 5, Ref. 26). Full Text in PDF www.elis.sk.

Recombinant human MMP-2 associated with monoolein improves bone repair

“…Matrix Metalloproteinases have a promising potential in the clinical procedures and medical treatment as a biomarker for several diseases (33,34). The critical defect made in calvaria of rodents is an in vivo model widely used to test the repair in several experimental situations for different strategies that aim to stimulate bone neoformation (31,35,36).…”

Paris saponin VII inhibits metastasis by modulating matrix metalloproteinases in colorectal cancer cells

“…In these steps, the expression of proteolytic enzymes, such as MMPs, is crucial for ECM degradation (25). Two members of the MMP family, the 72-kDa type IV collagenase MMP-2 (gelatinase A) and the 92-kD type IV collagenase MMP-9 (gelatinase B), have been shown to be highly expressed and to be important mediators in the pathogenesis of CRC metastasis (26). Increased MMP-2 and MMP-9 protein expression levels are associated with a poor prognosis in patients with CRC (27).…”